Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studies.

Ken-Ei SadaKeiji OhashiYosuke AsanoKeigo HayashiMichiko MorishitaHaruki WatanabeYoshinori MatsumotoShouichi FujimotoYoshinari TakasakiKunihiro YamagataShogo BannoHiroaki DobashiKoichi AmanoMasayoshi HarigaiYoshihiro ArimuraHirofumi Makinonull null

Published in: Arthritis research & therapy (2020)

A reduced initial GC dose with rapid reduction might be required to ensure the safe treatment of elderly AAV patients.

Keyphrases

ejection fraction
newly diagnosed
middle aged
prognostic factors
combination therapy
mass spectrometry
patient reported
gas chromatography